61 results about "Ear infection" patented technology

The present application concerns a device for measurement and analysis of the middle ear and ear channel color for the diagnosis of ear infections. The device is composed of a otoscope (1), including two optical fibers (2a and 2b): one for ear illumination and another returning the reflected light. The electronic unit (3) can change linearly the power of emitted light, as well as, its color. The received light is also independently measured, enabling the determination of changes on color and texture associated with the ear inflammations. Command buttons in the otoscope handler (4) enable the user to save the values of the three color components. The combined value of the components is shown in the digital display (5) of the electronic unit, as well as, by a set of LEDs (6) green, yellow and red that gives a diagnosis in a simple and immediate way. The otoscope allows, simultaneously, directly ear view through a magnifying glass (7) applied in the head of the otoscope, with a standard white light. This device is also useful in food industry.

The present invention relates in its broadest aspect to combined phage / antibiotic therapy. More particularly, it relates to use of (i) one or more bacteriophages and (ii) one or more antibiotics in the manufacture of a combined product for simultaneous, separate or sequential administration of (i) and (ii) to treat a bacterial infection characterized by biofilm formation, for example an infection comprising or consisting of P. aeruginosa. Treatment in this context may be either therapeutic or prophylactic treatment. Also provided are deposited bacteriophages each exhibiting different strain specificity against P. aeruginosa and combinations of such bacteriophages, e.g. a panel of six deposited bacteriophages which was found to be effective against a high percentage of clinical isolates of P. aeruginosa from canine ear infections.

The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.

Efflux pump inhibitors are co-administered with antimicrobial agents for the treatment of ophthalmic or otic infections. The agents may be co-administered directly to the site of infection (e.g., the eye or ear).

The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin / low molecular weight heparin derivative.

The present invention relates generally to a methods of treating ear infections and clearing excess fluid from Eustachian tubes.